Aurora Cannabis Inc. (ACB)


-0.00 (-0.19%)
Symbol ACB
Price $0.5143
Beta 3.000
Volume Avg. 3.49M
Market Cap 175.370M
Shares () -
52 Week Range 0.49-1.94
1y Target Est -
DCF Unlevered ACB DCF ->
DCF Levered ACB LDCF ->
ROE -243.85% Strong Sell
ROA -170.69% Strong Sell
Operating Margin -
Debt / Equity 76.74% Buy
P/E -0.09 Neutral
P/B 0.38 Neutral


Consensus EPS

Upgrades & Downgrades

Latest ACB news

Mr. Miguel Martin
Drug Manufacturers—Specialty & Generic
NASDAQ Global Select

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.